The effect of APRV-LTV mechanical ventilation mode in patients with COVID-19
Not Applicable
Recruiting
- Conditions
- COVID-19.COVID-19, virus identifiedU07.1
- Registration Number
- IRCT20150724023314N4
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Age over 18 years
No history of chronic respiratory diseases such as COPD
Having a endotracheal tube and being connected to mechanical ventilation
Exclusion Criteria
The patient refuses to participating in the study
Instability of the patient's vital signs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood pressure. Timepoint: Immediately before, 2 and 4 hours after the start of ventilation. Method of measurement: Vital Sign Monitoring Device.;Heart rate. Timepoint: Immediately before, 2 and 4 hours after the start of ventilation. Method of measurement: Vital Sign Monitoring Device.;Respiratory rate. Timepoint: Immediately before, 2 and 4 hours after the start of ventilation. Method of measurement: Vital Sign Monitoring Device.;Static compliance rate. Timepoint: Immediately before, 2 and 4 hours after the start of ventilation. Method of measurement: Vital Sign Monitoring Device.;PaO2 / FiO2 ratio. Timepoint: Immediately before, 2 and 4 hours after the start of ventilation. Method of measurement: Vital Sign Monitoring Device.;Arterial blood oxygen saturation. Timepoint: Immediately before, 2 and 4 hours after the start of ventilation. Method of measurement: Vital Sign Monitoring Device.
- Secondary Outcome Measures
Name Time Method